
PERATUNE-TZ 4.5G Injection by Fortune Labs contains Piperacillin 4 gm and Tazobactam 500 mg, a broad-spectrum antibiotic combination used to treat serious bacterial infections. Piperacillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam helps protect Piperacillin against certain bacterial beta-lactamase enzymes. PERATUNE-TZ may be prescribed for pneumonia, complicated urinary tract infections, intra-abdominal infections, and skin infections caused by susceptible bacteria. Available in 4.5 gm single-dose vial packaging, this product is part of Fortune Labs' injectable pharmaceutical range. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, and franchise enquiries. Administration requires healthcare professional supervision.PERATUNE-TZ 4.5G Injection by Fortune Labs contains Piperacillin 4 gm and Tazobactam 500 mg, a broad-spectrum antibiotic combination used to treat serious bacterial infections. Piperacillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam helps protect Piperacillin against certain bacterial beta-lactamase enzymes. PERATUNE-TZ may be prescribed for pneumonia, complicated urinary tract infections, intra-abdominal infections, and skin infections caused by susceptible bacteria. Available in 4.5 gm single-dose vial packaging, this product is part of Fortune Labs' injectable pharmaceutical range. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, and franchise enquiries. Administration requires healthcare professional supervision.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?